Results 301 to 310 of about 505,053 (355)

Reviewer #2 (Public review): Human multiethnic radiogenomics reveals low-abundancy microRNA signature in plasma-derived extracellular vesicles for early diagnosis and molecular subtyping of pancreatic cancer

openalex   +1 more source

EXPLORING MICRORNA EXPRESSION PATTERNS IN EARLY DETECTION AND PROGRESSION OF HEPATOCELLULAR CARCINOMA- SYSTEMATIC REVIEW

Irfan Ishaque, Murtaza Khodadadi, Hitender Thakur, Attiq Ullah, Amna Noor, Wafaa Jamal, Mariyam Waheed, Summyya Rasheed   +7 more
openalex   +2 more sources

[Retracted] MicroRNA‑615‑5p targets insulin‑like growth factor 2 and exerts tumor‑suppressing functions in human esophageal squamous cell carcinoma. [PDF]

Oncol Rep
Yang B, Xie R, Wu SN, Gao CC, Yang XZ, Zhou JF.   +5 more
europepmc   +1 more source

Retraction: MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase. [PDF]

Oncol Res
Oncology Research Editorial Office.
europepmc   +1 more source

RETRACTION: Clinicopathological Significance of the MicroRNA-146a/WASP-Family Verprolin-Homologous Protein-2 Axis in Gastric Cancer. [PDF]

Cancer Sci
europepmc   +1 more source

A Bilayer Feature Fusion Framework for Pan-Cancer Survival Prediction Based on Multihead Attention and Adaptive Differential Privacy: Model Development and Validation Study.

JMIR Med Inform
Chen Y, Deng Z, Wang L, Wang H, Wu X.
europepmc   +1 more source

A Circular RNA Derived from Golgi Glycoprotein 1 mRNA Regulates <i>KRAS</i> Expression and Promotes Colorectal Cancer Progression by Targeting microRNA-622 [Retraction]. [PDF]

Onco Targets Ther
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MicroRNA Targeting

2021
MicroRNAs (miRNAs) are small noncoding elements that play essential roles in the posttranscriptional regulation of biochemical processes. miRNAs recognize and target multiple mRNAs; therefore, investigating miRNA dysregulation is an indispensable strategy to understand pathological conditions and to design innovative drugs. Targeting miRNAs in diseases
Hossein, Ghanbarian, Mehmet Taha, Yıldız, Yusuf, Tutar   +2 more
openaire   +2 more sources